Earnings Alerts

China Petroleum & Chemical (386) Earnings: Sinopec Shanghai Reports 27.9M Yuan Net Income in 1H

  • Net income for Sinopec Shanghai in the first half of 2024 was 27.9 million yuan.
  • Total revenue for this period amounted to 43.53 billion yuan.
  • The earnings per share (EPS) was 0.300 RMB cents.
  • Analyst recommendations include:
    • 3 buys
    • 3 holds
    • 1 sell

A look at China Petroleum & Chemical Smart Scores

FactorScoreMagnitude
Value5
Dividend5
Growth3
Resilience3
Momentum5
OVERALL SMART SCORE4.2

Smart Score is a compound score for the Company indicating its overall outlook. It is derived by taking an equally weighted average of underlying Factor scores computed by Smartkarma

China Petroleum & Chemical Corporation, known for its strong performance in value, dividend payout, and momentum, presents a promising long-term outlook for investors. With top scores in both value and dividend factors, the company demonstrates stability and financial health. This indicates that it may be a wise choice for investors looking for consistent returns and income generation.

Although scoring slightly lower in growth and resilience factors, China Petroleum & Chemical Corporation remains well-positioned in the market. Its robust momentum score suggests a positive trend in stock performance, reflecting investor confidence and potentially signaling future growth opportunities. Overall, the company’s profile showcases a solid foundation in the petroleum and petrochemical industry, presenting a favorable outlook for long-term investment.


Disclaimer: This article by Smartkarma is general in nature and based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. Note that our articles may not factor in the latest price-sensitive company announcements or qualitative material.
While all reasonable care has been taken in the preparation, Smartkarma makes no assurance about the accuracy of any generated data or content. All content is indicative only and should be independently checked for accuracy and confirmed before use. Smartkarma accepts no responsibility for any loss or damage caused as a result of any inaccuracy or error within the Lab online tools or generated data.
Have feedback on this article? Concerned about the content? Get in touch with us directly.


 

πŸ’‘ Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • βœ“ Unlimited Research Summaries
  • βœ“ Personalised Alerts
  • βœ“ Custom Watchlists
  • βœ“ Company Analytics and News
  • βœ“ Events & Webinars